Australia targets Nurofen
Nurofen told to withdraw ad claims about ‘targeted relief’Pain relief brand Nurofen has been reprimanded by the Therapeutic Goods Administration over its claims of “targeted relief”.The Reckitt Benckiser brand was brought before the complaints resolution panel of the TGA over claims in the ad, made by Havas Worldwide, that Nurofen targets the source or cause of pain.In a decision, the TGA upheld the complaints and ordered that the brand withdraw “any representations that the advertised products target the source of pain or cause of pain”.It also ordered that the brand withdraw advertising that cl...
Source: PharmaGossip - July 9, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Healthcare Update Satellite — 06-26-2013
See more HealthCare Updates at my other blog at http://drwhitecoat.com.
UK Accident and Emergency Department criticized for multiple failures after going into “crisis” mode from January through March due to a surge in patient volumes. Of course, all the investigators go and pick through the hospital’s policies four times in April after things have calmed down, rather than going and trying to address the problems in real time while they’re happening.
Want to see me faint? Give me a story about an inspector going to a hospital during a crisis, and making a specific real-time recommendation on how to improve the ...
Source: WhiteCoat's Call Room - June 27, 2013 Category: Emergency Medicine Doctors Authors: WhiteCoat Tags: Healthcare Update Source Type: blogs
Doing Business Under Fire
Dalibor Rohac
Since its inception, World Bank’s Doing Business project has attracted a lot of criticism from groups that do not share its broadly pro-market policy ramifications. It is dispiriting to see the review panel of the project, appointed by the Bank’s president, Jim Yong Kim, cave to the attacks and regurgitate the ideologically motivated myths spread by the project’s most vocal critics.
The report by the review panel, which was released on Monday, and which will inform the decision about the future of the project, recommends stripping the publication of important parts of its content an...
Source: Cato-at-liberty - June 25, 2013 Category: Health Medicine and Bioethics Commentators Authors: Dalibor Rohac Source Type: blogs
FDA Expanding Role of Office of Criminal Investigations
Over the last year or two, the Food and Drug Administration's (FDA) Office of Criminal Investigations (OCI) has grown to play a crucial role in protecting the public health from fraudulent or counterfeit drugs, devices, cosmetics and other FDA regulated products. Increasingly, OCI has also played a large role in several recent high-profile settlements involving off-label marketing or deceptive promotional practices.
Several recent posts on the FDAVoice blog, written by OCI's director, John Roth, explain the work OCI has done in the past and what the future holds.
OCI consists of numerous federal agents, who have t...
Source: Policy and Medicine - June 20, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
Instead of Free Trade, Have the Transatlantic Trade Talks
Daniel J. Ikenson
Has the intellectual debate about free trade been won? The close-to-consensus answer among several scholars discussing that question at Cato last week is “yes.” The better answer is “wrong question.” After all, how much does it really matter that free traders have won the intellectual debate when, in practice, trade policy is distinctly anti-intellectual and free trade is the rare exception, not the rule, around the world?
Consider the just-launched Transatlantic Trade and Investment Partnership negotiations. If the free trade consensus were meaningful outside the ivory tower, these negotiations ...
Source: Cato-at-liberty - June 18, 2013 Category: Health Medicine and Bioethics Commentators Authors: Daniel J. Ikenson Source Type: blogs
